December 2020 to March 2022 We conducted the following clinical trial. "A bioequivalence Study of an Anti-Cancer Drug in Healthy Volunteers" - 京都大学医学部附属病院次世代医療・iPS細胞治療研究センター（Ki-CONNECT）早期医療開発科大学院医学研究科早期医療開発学 | Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy（Ki-CONNECT）Department of Early Clinical Development | Department of Early Clinical Development Graduate School of Medicine | 京都大学医学部附属病院次世代医療・iPS細胞治療研究センター（Ki-CONNECT）早期医療開発科大学院医学研究科早期医療開発学 | Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy（Ki-CONNECT）Department of Early Clinical Development